ArticleOncotarget2016

Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.